Northwire Canada EditionThursday, October 15, 2026
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
M&A / Property

AlphaGen Announces Definitive Agreement to Acquire Quantum Vision Holdings Inc.

AlphaGen Halts Trading on Quantum Vision Buyout as Dilution Looms Over AI Pivot

Executive Summary
  • AlphaGen Intelligence Corp. announced a definitive share-exchange agreement to acquire 100% of Quantum Vision Holdings Inc.
  • The transaction is structured as a 1:1 share exchange, issuing 24,500,001 AlphaGen common shares to Quantum Vision shareholders.
  • The implied value of the transaction is $0.40 per AlphaGen share, with zero cash consideration or finder’s fees.
  • Upon closing, expected by July 31, 2026, Quantum Vision will become a wholly-owned subsidiary.
  • Kyle Klemmer, current CEO of Quantum Vision, will assume the CEO role of the combined entity, with Matthew Morgan joining the board.
  • The Canadian Investment Regulatory Organization (CIRO) placed a trading halt on all AlphaGen issues at 8:51 AM ET on March 31, 2026, pending CSE review of this fundamental change.
  • Shareholder approval is required via written consent or a special meeting.
Material Impact
  • The acquisition represents a fundamental shift in corporate structure and operations, triggering a regulatory trading halt.
  • The $0.40 implied valuation aligns exactly with the stock’s recent trading range, indicating no acquisition premium and suggesting the deal is priced to current market sentiment rather than intrinsic value.
  • Issuing 24.5 million new shares will cause severe dilution to existing shareholders, likely exceeding 50% of the post-transaction float depending on the exact pre-deal share count.
  • The absence of cash consideration preserves near-term liquidity but shifts the entire risk profile to execution and integration of Quantum Vision’s unproven assets.
  • The trading halt introduces immediate uncertainty; resumption of trading will depend on CSE approval and the filing of a comprehensive listing statement, which may reveal undisclosed liabilities or operational gaps.
AIC · Price
Company Overview
  • AlphaGen Intelligence Corp. is a Canadian micro-cap company operating in the artificial intelligence and technology sector.
  • Prior to the M&A announcement, the company lacked a clearly defined flagship project or revenue-generating product in the provided disclosures, operating primarily as a development-stage entity.
  • The acquisition of Quantum Vision Holdings Inc. is intended to serve as the new flagship operation, pivoting the company toward Quantum Vision’s technology and business model.
  • No specific details regarding Quantum Vision’s products, patents, or revenue streams were provided in the press release, leaving the core asset unverified.
Read the original news release →

More from AlphaGen Intelligence Corp.